Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02925884 · ClinicalTrials.gov registry record · NA
Effects of Gunnar Computer Glasses on Viewing Comfort and Performance
A NA study, sponsored by Pacific University.
- Terminated
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT02925884: Clinical Trial NA study, sponsored by Pacific University.
NCT02925884 is a NA study that was terminated before completion, run by Pacific University. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02925884, a NA study, was terminated before completion, sponsored by Pacific University.
- TERMINATED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
The proposed study aims to test if Gunnar computer glasses provide any advantages, in comparison to no glasses, on the following aspects in computer-related office work: * Any enhancement on the visual performance of the basic visual function, including visual acuity, contrast sensitivity, color discrimination, etc. * Any enhancement on the visual performance of typical office work, including reading, word-spelling check, number searching, or target identification. * Any benefit in objective viewing comfort measured with viewing distance, blink frequency, post-viewing pupil size. * Any benefit in subjective viewing comfort reflected on the questionnaire of viewing symptom survey. * Any benefit in viewing comfort and visual performance with increased environmental ventilation or under the strong glare. * Any benefit in life quality from daily wearing (e.g., better comfort or sleep quality).
Primary Outcome
At the end of the study in Visit 3, subjects were asked to respond if they felt the Gunnar TC Glasses improved their computer viewing comfort and visual performance (choose between "Yes" and "No").
Interventions
- DEVICE Gunnar OTC Glasses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2013-06 |
| Est. Completion | 2013-09 |
| Phase | NA |
Why NCT02925884 stopped before completion
NCT02925884 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Gunnar OTC Glasses is the first listed.
NCT02925884 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02925884 about?
NCT02925884 is a clinical study titled "Effects of Gunnar Computer Glasses on Viewing Comfort and Performance". The proposed study aims to test if Gunnar computer glasses provide any advantages, in comparison to no glasses, on the following aspects in computer-related office work: * Any enhancement on the visual performance of the basic visual function, including visual acuity, contrast sensitivity, color di...
What is the current status of trial NCT02925884?
This trial is currently terminated. It is a NA study. The enrollment target is 35 participants. The study started on 2013-06. Estimated completion is 2013-09.
What interventions are being tested in trial NCT02925884?
The interventions under investigation include: Gunnar OTC Glasses (DEVICE).
Who is sponsoring clinical trial NCT02925884?
This trial is sponsored by Pacific University, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02925884's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia